Skip to main content
Innovotech Inc. logo

Innovotech Inc. — Investor Relations & Filings

Ticker · IOT ISIN · CA45772U1049 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 330 across all filing types
Latest filing 2022-04-27 Regulatory Filings
Country CA Canada
Listing TSXV IOT

About Innovotech Inc.

https://innovotech.ca/

Innovotech Inc. is a specialist in antimicrobial and biofilm solutions, recognized as a pioneer in biofilm product development and contract research. The company focuses on providing innovative and practical solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Key offerings include specialized assay kits used globally for growing microbial biofilms in research applications. Through Innovotech Labs, the company provides comprehensive, accredited (GMP and ISO) contract testing services, including analytical, microbiological, and antimicrobial testing. These services target the pharmaceutical, biotechnology, medical device, and nutraceutical industries, aiming to ensure regulatory compliance and product optimization.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Regulatory Filings
2022-04-27 English
Audited annual financial statements – English.pdf
Regulatory Filings
2022-04-27 English
News release - English.pdf
Regulatory Filings
2022-01-21 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a financial report detailing Innovotech Inc.'s financial results for the three and nine months ended September 30, 2021. It includes specific financial data such as revenue, gross profit, net operating expenses, interest income, and net profit/loss for both the quarter and nine-month period. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 4206 characters, which is sufficient to contain substantive financial data rather than just an announcement or summary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2021
2021-11-16 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The text explicitly states it is a certification letter and does not contain the actual interim financial data or analysis itself. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) they reference. The document length is short (3028 characters), consistent with a certification letter rather than a full interim report. Therefore, the correct classification is Regulatory Filings (RNS).
2021-11-16 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document text is extremely short (66 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-11-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.